greeksoup/ stock research

Johnson & Johnson (JNJ) FY2020 results: revenue $82.6 billion, up 0.6% on the year

Johnson & Johnson (JNJ) reported revenue of $82.6 billion for fiscal 2020, the year ended 3 January 2021, up 0.6% on the year before. Net income was $14.7 billion, down 2.7%, and diluted earnings per share $5.51. The figures are the company's own, from the 10-K it filed with the SEC on 22 February 2021.

Revenue
$82.6 billion
+0.6% on the year
FY2013FY2020
Operating margin
n/a
FY2013FY2020
Net income
$14.7 billion
-2.7% on the year
FY2013FY2020
Diluted EPS
$5.51
-2.1% on the year
FY2013FY2020

this yearthe year beforeHover a bar for its figure.

The year in brief

Income statement (profit and loss)

$ millionFY2020FY2019FY2018On the yearLast 8 years
Revenue82,58482,05981,581+0.6%
Cost of revenue28,42727,55627,091+3.2%
Gross profit54,15754,50354,490-0.6%
Gross margin65.6%66.4%66.8%
Research and development12,15911,35510,775+7.1%
Selling, general and administrative22,08422,17822,540-0.4%
Interest expense2013181,005-36.8%
Pre-tax income16,49717,32817,999-4.8%
Income tax1,7832,2092,702-19.3%
Effective tax rate10.8%12.7%15.0%
Net income14,71415,11915,297-2.7%
Net margin17.8%18.4%18.8%
Diluted EPS$5.51$5.63$5.61-2.1%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2020FY2019FY2018On the yearLast 8 years
Operating cash flow23,53623,41622,201+0.5%
Capital expenditure3,3473,4983,670-4.3%
Free cash flow20,18919,91818,531+1.4%
Free cash flow margin24.4%24.3%22.7%
Cash from investing-20,825-6,194-3,167
Cash from financing-6,120-18,015-18,510
Depreciation and amortisation7,2317,0096,929+3.2%
Share-based compensation1,005977978+2.9%
Buybacks3,2216,7465,868-52.3%
Dividends paid10,4819,9179,494+5.7%
Dividend per share$3.98$3.75$3.54+6.1%
Diluted shares, weighted2,671m2,684m2,729m-0.5%

Balance sheet

$ millionFY2020FY2019FY2018On the yearLast 8 years
Shareholders' equity63,27859,47159,752+6.4%
Debt35,26627,69630,480+27.3%
Operating lease liabilitiesn/a716n/a
Other liabilities76,35069,84562,722+9.3%
Total liabilities and equity174,894157,728152,954+10.9%
Fixed assets18,76617,65817,035+6.3%
Goodwill36,39333,63930,453+8.2%
Intangible assets53,40247,64347,611+12.1%
Investments11,2001,9821,580+465.1%
Cash and equivalents13,98517,30518,107-19.2%
Receivables13,57614,48114,098-6.2%
Inventory9,3449,0208,599+3.6%
Other assets18,22816,00015,471+13.9%
Total assets174,894157,728152,954+10.9%

10-K for the year ended 3 January 2021, filed 22 February 2021: the filing.